| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |